These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6310691

  • 1. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
    Globus M, Melamed E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):211-5. PubMed ID: 6310691
    [Abstract] [Full Text] [Related]

  • 2. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 3. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M, Bannet J, Lerer B, Belmaker RH.
    Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
    Melamed E, Rosenthal J, Globus M, Cohen O, Uzzan A.
    Brain Res; 1985 Sep 09; 342(2):401-4. PubMed ID: 3876139
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S, Watanabe A, Takahashi R.
    Eur J Pharmacol; 1986 Apr 16; 123(2):287-94. PubMed ID: 3086109
    [Abstract] [Full Text] [Related]

  • 11. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM, Walters JR, Miller LP.
    Brain Res; 1982 Nov 04; 250(2):271-82. PubMed ID: 6129029
    [Abstract] [Full Text] [Related]

  • 12. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K, Dluzen DE.
    J Neural Transm (Vienna); 1996 Nov 04; 103(11):1295-305. PubMed ID: 9013416
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 04; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D, Abercrombie ED, Zigmond MJ.
    J Pharmacol Exp Ther; 1993 Nov 04; 267(2):912-8. PubMed ID: 8246167
    [Abstract] [Full Text] [Related]

  • 19. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 04; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 20. Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
    Gołembiowska K, Dziubina A.
    Brain Res; 2004 Feb 20; 998(2):208-17. PubMed ID: 14751592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.